✦ LIBER ✦

Risk of cancer in liver transplant recipients: A look into the mirror

✍ Scribed by Joseph F. Buell; Guy N. Brock

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 64 KB
Volume: 14
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21634

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The immunological monitoring of alloreac

The immunological monitoring of alloreactive responses in liver transplant recipients: A review

✍ Raymond Reding; Jérémie Gras; Dinh Quang Truong; Grégoire Wieërs; Dominique Lati 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

The aim of this work is to review the current knowledge in the field of immunological monitoring of allogenic responsiveness in clinical liver transplantation. When compared to other solid-organ transplants, liver allografts are considered as immunologically privileged, and, accordingly, constitute

The natural history of hepatitis C virus

The natural history of hepatitis C virus in pediatric liver transplant recipients

✍ Neal R. Barshes; Ian W. Udell; Timothy C. Lee; Christine A. O'Mahony; Saul J. Ka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients

Validation of a current definition of ea

Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors

✍ Kim M. Olthoff; Laura Kulik; Benjamin Samstein; Mary Kaminski; Michael Abecassis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

Translational studies in liver transplantation often require an endpoint of graft function or dysfunction beyond graft loss. Prior definitions of early allograft dysfunction (EAD) vary, and none have been validated in a large multicenter population in the Model for End-Stage Liver Disease (MELD) era

A look into the past and into the future

A look into the past and into the future in cancer of the breast

✍ William L. Ross 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 2 views

Avoiding calcineurin inhibitors in the e

Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis

✍ Lucio Urbani; Alessandro Mazzoni; Paolo De Simone; Gabriele Catalano; Laura Cole 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract The aim of this work is to report on the results of a single‐center, prospective study on the feasibility of calcineurin‐inhibitor (CNI)‐staggered immunosuppression by use of extracorporeal photopheresis (ECP) in liver transplant (LT) recipients at risk of renal and neurological complic

Increased incidence of cytomegalovirus i

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis

✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos